![Jonathan Bramson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Bramson
Gründer bei Triumvira Immunologics, Inc.
Ursprung des Netzwerks ersten Grades von Jonathan Bramson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Triumvira Immunologics, Inc.
![]() Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Mcmaster Innovation Park
![]() Mcmaster Innovation Park Miscellaneous Commercial ServicesCommercial Services Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada.
9
| Private Company | Miscellaneous Commercial Services | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jonathan Bramson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
JMP Securities LLC
![]() JMP Securities LLC Investment Banks/BrokersFinance Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate. | Investment Banks/Brokers | Corporate Officer/Principal | |
NewLeaf Symbiotics, Inc.
![]() NewLeaf Symbiotics, Inc. Chemicals: AgriculturalProcess Industries NewLeaf Symbiotics, Inc. develops and commercializes a family of beneficial bacteria. It commercializes Pink Pigmented Facultative Methylotrophs bacteria that improves plant health, promote early growth, and increase crop yield. The company was founded by Stephen Kahn, Thomas R. Laurita and Michael Bielski in 2012 and is headquartered in St. Louis, MO. | Chemicals: Agricultural | Director/Board Member | |
Burrill LLC
![]() Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
Stanford University | College/University | Doctorate Degree | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
University of Toronto | College/University | Corporate Officer/Principal Masters Business Admin | |
McMaster University | College/University | Corporate Officer/Principal Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
State University of New York at Binghamton | College/University | Undergraduate Degree | |
CureDuchenne
![]() CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | Financial Conglomerates | Corporate Officer/Principal | |
CoverCress, Inc.
![]() CoverCress, Inc. Information Technology ServicesTechnology Services CoverCress, Inc. operates as a renewable fuel company. It develops and commercializes field pennycress as an oilseed crop that is used to produces oil for industrial and renewable fuels, and meal for nutritious livestock feed. The company was founded by Vijay Chauhan, Dennis M. Plummer and Mike Roth and is headquartered in St. Louis, MO. | Information Technology Services | Director/Board Member | |
MyoTherix, Inc.
![]() MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Myotherix, Inc. operates as a biopharmaceutical company focuses on the development of therapies. It focuses on the development of innovative therapies for patients suffering from Duchenne muscular dystrophy and other muscle disorders for which there are no treatments. The company was founded by John Kincaid and is headquartered in Emeryville, CA. | Pharmaceuticals: Major | Director/Board Member | |
Informed Data Systems, Inc.
![]() Informed Data Systems, Inc. Packaged SoftwareTechnology Services Informed Data Systems, Inc. is a biotechnology comapny, which engages in the provision of healthcare services. The company was founded by Jeffrey A. Dachis and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
Bamboo Therapeutics, Inc.
![]() Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Biotechnology | Consultant / Advisor | |
APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CureDuchenne Ventures LLC
![]() CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Investment Managers | Private Equity Investor | |
eGenesis, Inc.
![]() eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
BlueRock Therapeutics Canada ULC
![]() BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Agent Capital LLC
![]() Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Consultant / Advisor | |
StrideBio, Inc.
![]() StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Camp4 Therapeutics Corp.
![]() Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Ada Health GmbH
![]() Ada Health GmbH Internet Software/ServicesTechnology Services Ada Health GmbH offers a virtual assessment of health symptoms. It specializes in Personal Health, Artificial Intelligence, mHealth and Health Care services. The company was founded by Martin Hirsch, Daniel Nathrath and Claire Novorol and is headquartered in Berlin, Germany. | Internet Software/Services | Director/Board Member | |
Exonics Therapeutics, Inc.
![]() Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Biotechnology | President | |
Casebia Therapeutics LLP
![]() Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member | |
Joyn Bio LLC
![]() Joyn Bio LLC Real Estate DevelopmentFinance Joyn Bio LLC is a joint venture between Leaps by Bayer and Ginkgo Bioworks that engineers microbes to improve naturally occurring processes in agriculture. The company is based in Boston, MA, and has two sites for leading scientists with diverse backgrounds. The company's focus is on developing probiotics for plants to provide growers with next-generation solutions to their biggest challenges. The company's first area of focus is on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture's reliance on nitrogen fertilizer and its environmental impact. | Real Estate Development | Director/Board Member | |
Khloris Biosciences, Inc.
![]() Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Dewpoint Therapeutics, Inc.
![]() Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Leaps by Bayer
![]() Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Private Equity Investor | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
RASRx LLC
![]() RASRx LLC Miscellaneous Commercial ServicesCommercial Services RASRx LLC provides research and development laboratories services. The company is headquartered in San Luis Obispo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
VIATRIS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Immunitas Therapeutics, Inc.
![]() Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
DICE Molecules SV, Inc.
![]() DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
Oerth Bio LLC
![]() Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Biotechnology | Director/Board Member | |
Trinds LLC
![]() Trinds LLC Miscellaneous Commercial ServicesCommercial Services Trinds LLC operates as a contract research organization which conducts research in neuromuscular and rare disorders. It offers solutions in clinical operations, data management, patient science liaison services, study measurements, and biostatistics. The company was founded by Avital Cnaan, Heather Gordish-Dressman and Eric Hoffman and is headquartered in Pittsburgh, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Vesigen, Inc.
![]() Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
METAGENOMI, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Triumvira Immunologics USA, Inc.
![]() Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Director/Board Member | |
SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Incendia Therapeutics, Inc.
![]() Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Director/Board Member | |
Affini-T Therapeutics, Inc.
![]() Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Biotechnology | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 38 |
Kanada | 7 |
Deutschland | 4 |
Vereinigtes Königreich | 3 |
Frankreich | 2 |
Sektoral
Health Technology | 23 |
Finance | 10 |
Commercial Services | 8 |
Consumer Services | 7 |
Technology Services | 4 |
Operativ
Director/Board Member | 111 |
Corporate Officer/Principal | 30 |
Chief Executive Officer | 19 |
President | 18 |
Independent Dir/Board Member | 13 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jürgen Eckhardt | 34 |
Cynthia Collins | 27 |
Jak Knowles | 24 |
Shaan Gandhi | 22 |
Scott Smith | 21 |
Brian Bloom | 15 |
Tony Fiorino | 13 |
Paul Lammers | 7 |
Julie Yang | 7 |
Vigen Nazarian | 6 |
John Holyoake | 6 |
Roger Couldrey | 5 |
Mario Frankovich | 5 |
Ty Shattuck | 4 |
David Farrar | 2 |
- Börse
- Insiders
- Jonathan Bramson
- Unternehmensverbindungen